Computational modelling reveals feedback redundancy within the epidermal growth factor receptor/extracellular-signal

R J Orton1, O E Sturm, A Gormand

  • 1Bioinformatics Research Centre, Department of Computing Science, University of Glasgow, Glasgow, UK. rorton@dcs.gla.ac.uk

IET Systems Biology
|August 7, 2008
PubMed

Insights

Epidermal growth factor receptor (EGFR) signaling normally activates extracellular-signal regulated kinase (ERK) transiently. Computational models show receptor degradation, not feedback loops, terminates ERK signals, crucial for understanding cancer.

Area of Science:

  • Cellular biology
  • Systems biology
  • Cancer research

Background:

  • The epidermal growth factor receptor (EGFR) activated extracellular-signal regulated kinase (ERK) pathway is central to cell proliferation, survival, and motility.
  • Dysregulation of this pathway, via mutation or overexpression, is linked to various cancers, often resulting in sustained ERK signaling instead of transient activation.

Purpose of the Study:

  • To investigate the signaling dynamics of the EGFR/ERK pathway using computational modeling.
  • To identify key processes in signal termination and the role of the ERK to son of sevenless (SOS) negative feedback loop in generating transient responses.

Main Methods:

  • Computational modeling of the EGFR/ERK signaling pathway.
  • Verification of model predictions with laboratory data.
  • Analysis of feedback loop and receptor degradation roles in signal termination.

Main Results:

  • The model predicts that receptor degradation alone is sufficient for transient ERK activation, rendering the ERK to SOS negative feedback loop non-essential.
  • Both receptor degradation and the negative feedback loop were found to be redundant, with each capable of compensating for the absence of the other.
  • The study predicts that for non-degraded receptors like the insulin receptor, the negative feedback loop to SOS becomes essential for achieving a transient response.

Conclusions:

  • Negative feedback plays a nuanced role in EGFR signaling, with receptor degradation being the primary mechanism for transient ERK activation.
  • Different receptors may rely on distinct pathway features for signal termination, highlighting the complexity of cellular signaling networks.
  • These findings offer new insights into EGFR signaling and have implications for understanding cancer biology and therapeutic strategies.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...